HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 194 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $92 | -99.9% | 2,416 | -21.0% | 0.00% | – |
| Q4 2021 | $122,000 | +351.9% | 3,057 | +386.0% | 0.00% | – |
| Q4 2020 | $27,000 | -22.9% | 629 | -51.7% | 0.00% | – |
| Q2 2020 | $35,000 | -64.3% | 1,302 | -76.2% | 0.00% | -100.0% |
| Q1 2020 | $98,000 | -80.9% | 5,465 | -81.1% | 0.00% | -50.0% |
| Q4 2019 | $512,000 | +196.0% | 28,896 | +186.3% | 0.00% | +100.0% |
| Q2 2019 | $173,000 | -4.4% | 10,094 | -10.2% | 0.00% | 0.0% |
| Q1 2019 | $181,000 | -77.1% | 11,246 | -74.1% | 0.00% | -66.7% |
| Q3 2018 | $789,000 | -45.6% | 43,469 | -49.5% | 0.00% | -50.0% |
| Q2 2018 | $1,451,000 | -80.8% | 86,061 | -77.7% | 0.01% | -81.8% |
| Q1 2018 | $7,572,000 | +151340.0% | 386,420 | +188397.6% | 0.03% | – |
| Q2 2015 | $5,000 | – | 205 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |